VHR-IN-2 (Compound SA9) is a selective vaccinia H1-related ( VHR ) phosphatase inhibitor with an IC 50 of 3.1 μM. VHR-IN-2 can be used for the research of cervical cancer .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phosphatase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.